Doxorubicin–PAMAM dendrimer complex attached to liposomes: Cytotoxic studies against human cancer cell lines

This publication has 10 references indexed in Scilit:

• Dendrimers: a new class of nanoscopic containers and delivery devices
  European Polymer Journal, 2003
• Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers
  International Journal of Pharmaceutics, 2003
• The Cytoprotective Aminothiol WR1065 Activates p53 through a Non-genotoxic Signaling Pathway Involving c-Jun N-terminal Kinase
  Journal of Biological Chemistry, 2003
• Biological applications of dendrimers
  Current Opinion in Chemical Biology, 2002
• A Novel Dendrimeric “Glue” for Adhesion of Phosphatidyl Choline-Based Liposomes
  Langmuir, 2002
• Interaction of cationic partial dendrimers with charged and neutral liposomes
  International Journal of Pharmaceutics, 2001
• Synthesis of Polyamidoamine Dendrimers Having Poly(ethylene glycol) Grafts and Their Ability To Encapsulate Anticancer Drugs
  Bioconjugate Chemistry, 2000
• Development of liposomal anthracyclines: from basics to clinical applications1This paper is based on a lecture presented at the 8th International Symposium on recent Advances in Drug Delivery Systems (Salt Lake City, UT, USA, 1997).1
  Journal of Controlled Release, 1998
• In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1992
• Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines
  JNCI Journal of the National Cancer Institute, 1991